Article

You have full text access to this OnlineOpen article

Amyloidogenic sequences in native protein structures

  1. Susan Tzotzos,
  2. Andrew J. Doig*

Article first published online: 21 DEC 2009

DOI: 10.1002/pro.314

Issue

Protein Science

Protein Science

Volume 19, Issue 2, pages 327–348, February 2010

Additional Information

How to Cite

Tzotzos, S. and Doig, A. J. (2010), Amyloidogenic sequences in native protein structures. Protein Science, 19: 327–348. doi: 10.1002/pro.314

Author Information

  1. Manchester Interdisciplinary Biocentre, The University of Manchester, Manchester M1 7DN, United Kingdom

*Manchester Interdisciplinary Biocentre, The University of Manchester, 131 Princess Street, Manchester M1 7DN, United Kingdom

Publication History

  1. Issue published online: 21 JAN 2010
  2. Article first published online: 21 DEC 2009
  3. Accepted manuscript online: 21 DEC 2009 12:00AM EST
  4. Manuscript Accepted: 8 DEC 2009
  5. Manuscript Revised: 10 NOV 2009
  6. Manuscript Received: 11 SEP 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (392K)

References

  • 1
    Guijarro JI, Sunde M, Jones JA, Campbell ID, Dobson CM ( 1998). Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci USA 95: 4224–4228.
  • 2
    Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, Dobson CM ( 1999). Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA 90: 3590–3594.
  • 3
    Fändrich M, Forge V, Buder K, Kittler M, Dobson CM, Diekmann S ( 2003). Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments. Proc Natl Acad Sci USA 100: 15463–15468.
  • 4
    Dobson CM ( 2003). Protein folding and misfolding. Nature 426: 884–890.
  • 5
    Thirumalai D, Klimov DK, Dima RI ( 2003). Emerging ideas on the molecular basis of protein and peptide aggregation. Curr Opin Struct Biol 13: 146–159.
  • 6
    Makin OS, Serpell LC ( 2005). Structures for amyloid fibrils. FEBS J 272: 5950–5961.
    Direct Link:
  • 7
    Haass C, Selkoe DJ ( 2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat Rev Mol Cell Biol 8: 101–112.
  • 8
    Dobson CM ( 1999). Protein misfolding, evolution and disease. Trends Biochem Sci 24: 329–332.
  • 9
    Stefani M, Dobson CM ( 2003). Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81: 678–699.
  • 10
    Uversky VN, Fink AL ( 2004). Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta 1698: 131–153.
  • 11
    Ventura S, Zurdo J, Narayanan S, Parreno M, Mangues R, Reif B, Chiti F, Giannoni E, Dobson CM, Aviles FX ( 2004). Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci USA 101: 7258–7263.
  • 12
    Kenney JM, Knight D, Wise MJ, Vollrath F ( 2002). Amyloidogenic nature of spider silk. Eur J Biochem 269: 4159–4163.
    Direct Link:
  • 13
    Kelly JW, Balch WE ( 2003). Amyloid as a natural product. J Cell Biol 161: 461–462.
  • 14
    Chiti F, Dobson CM ( 2006). Protein misfolding, functional amyloid, and human disease. Ann Rev Biochem 75: 333–366.
  • 15
    Iconomidou VA, Chryssikos GD, Gionis V, Galanis AS, Cordopatis P, Hoenger A, Hamodrakas SJ ( 2006). Amyloid fibril formation propensity is inherent into the hexapeptide tandemly repeating sequence of the central domain of silkmoth chorion proteins of the A-family. J Struc Biol 156: 480–488.
  • 16
    Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, Kelly JW ( 2006). Functional amyloid formation within mammalian tissue. PLoS Biol 4: e6.
  • 17
    Fowler DM, Koulov AV, Balch WE, Kelly JW ( 2007). Functional amyloid – from bacteria to humans. Trends Biochem Sci 32: 217–224.
  • 18
    Sunde M, Serpell LC, Bartlam M, Fraser PE, Pepys MB, Blake CC ( 1997). Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol 273: 729–739.
  • 19
    Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R ( 2002). A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 99: 16742–16747.
  • 20
    Tycko R ( 2004). Progress towards a molecular-level structural understanding of amyloid fibrils. Curr Opin Struct Biol 14: 96–103.
  • 21
    Tycko R ( 2006). Molecular structure of amyloid fibrils: insights from solid state NMR. Quart Rev Biophys 39: 1–55.
  • 22
    Wilson LM, Mok YF, Binger KJ, Griffin MD, Mertens HD, Lin F, Wade JD, Gooley PR, Howlett GJ ( 2007). A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis. J Mol Biol 366: 1639–1651.
  • 23
    Rousseau F, Schymkowitz J, Serrano L ( 2006). Protein aggregation and amyloidosis: confusion of the kinds?. Curr Opin Struc Biol 16: 118–126.
  • 24
    Nichols MR, Moss MA, Reed DK, Cratic-Mcdaniel S, Hoh JH, Rosenberry TL ( 2005). Amyloid-β protofibrils differ from amyloid-β aggregates induced in dilute hexafluoroisopropanol in stability and morphology. J Biol Chem 280: 2471–2480.
  • 25
    Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M ( 2002). Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507–511.
  • 26
    Baglioni S, Casamenti F, Bucciantini M, Luheshi LM, Taddei N, Chiti F, Dobson CM, Stefani M ( 2006). Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci 26: 8160–8167.
  • 27
    Kallberg Y, Gustafsson M, Persson B, Thyberg J, Johansson J ( 2001). Prediction of amyloid fibril-forming proteins. J Biol Chem 276: 12945–12950.
  • 28
    Chiti F, Taddei N, Baroni F, Capanni C, Stefani M, Ramponi G, Dobson CM ( 2002). Kinetic partitioning of protein folding and aggregation. Nat Struct Biol 9: 137–143.
  • 29
    Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM ( 2003). Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424: 805–808.
  • 30
    Johansson J ( 2003). Molecular determinants for amyloid fibril formation: lessons from lung surfactant protein C. Swiss Med Wkly 133: 275–282.
  • 31
    Chien P, Weissman JS, Depace AH ( 2004). Emerging principles of conformation-based prion inheritance. Ann Rev Biochem 73: 617–656.
  • 32
    Dubay KF, Pawar AP, Chiti F, Zurdo J, Dobson CM, Vendruscolo M ( 2004). Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J Mol Biol 341: 1317–1326.
  • 33
    Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L ( 2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 22: 1302–1306.
  • 34
    Lopez De La Paz M, Serrano L ( 2004). Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci USA 101: 87–92.
  • 35
    Pastor MT, Esteras-Chopo A, De La Paz MT ( 2005). Design of model systems for amyloid formation: lessons for prediction and inhibition. Curr Opin Struct Biol 15: 57–63.
  • 36
    Pawar AP, Dubay KF, Zurdo J, Chiti F, Vendruscolo M, Dobson CM ( 2005). Prediction of ‘aggregation-prone’ and ‘aggregation-susceptible’ regions in proteins associated with neurodegenerative diseases. J Mol Biol 350: 379–392.
  • 37
    Sanchez De Groot N, Pallares I, Aviles FX, Vendrell J, Ventura S ( 2005). Prediction of “hot spots” of aggregation in disease-linked polypeptides. BMC Struc Biol 5: 18.
  • 38
    Tartaglia GG, Cavalli A, Pellarin R, Caflisch A ( 2005). Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences. Protein Sci 14: 2723–2734.
    Direct Link:
  • 39
    Caflisch A ( 2006). Computational models for the prediction of polypeptide aggregation propensity. Curr Opin Chem Biol 10: 437–444.
  • 40
    Thompson MJ, Sievers SA, Karanicolas J, Ivanova MI, Baker D, Eisenberg D ( 2006). The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci USA 103: 4074–4078.
  • 41
    Conchillo-Sole O, De Groot NS, Aviles FX, Vendrell J, Daura X, Ventura S ( 2007). AGGRESCAN: a server for the prediction and evaluation of “hot spots” of aggregation in polypeptides. BMC Bioinform 8: 65.
  • 42
    Tartaglia GG, Cavalli A, Vendruscolo M ( 2007). Prediction of local structural stabilities of proteins from their amino acid sequences. Structure 15: 139–143.
  • 43
    Azriel R, Gazit E ( 2001). Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation. J Biol Chem 276: 34156–34161.
  • 44
    Schwartz R, King J ( 2006). Frequencies of hydrophobic and hydrophilic runs and alternations in proteins of known structure. Protein Sci 15: 102–112.
    Direct Link:
  • 45
    Lopez De La Paz M, Goldie K, Zurdo J, Lacroix E, Dobson CM, Hoenger A, Serrano L ( 2002). De novo designed peptide-based amyloid fibrils. Proc Natl Acad Sci USA 99: 16052–16057.
  • 46
    Chiti F, Calamai M, Taddei N, Stefani M, Ramponi G, Dobson CM ( 2002). Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci USA 99: 16419–16426.
  • 47
    Schmittschmitt JP, Scholtz JM ( 2003). The role of protein stability, solubility, and net charge in amyloid fibril formation. Protein Sci 12: 2374–2378.
    Direct Link:
  • 48
    Calloni G, Zoffoli S, Stefani M, Dobson CM, Chiti F ( 2005). Investigating the effects of mutations on protein aggregation in the cell. J Biol Chem 280: 10607–10613.
  • 49
    Paivio A, Nordling E, Kallberg Y, Thyberg J, Johansson J ( 2004). Stabilization of discordant helices in amyloid fibril-forming proteins. Protein Sci 13: 1251–1259.
    Direct Link:
  • 50
    Broome BM, Hecht MH ( 2000). Nature disfavors sequences of alternating polar and non-polar amino acids: implications for amyloidogenesis. J Mol Biol 296: 961–968.
  • 51
    Williams AD, Portelius E, Kheterpal I, Guo J, Cook JD, Xu Y, Wetzel R ( 2004). Mapping Abeta Amyloid fibril secondary structure using scanning proline mutagenesis. J Mol Biol 335: 833–842.
  • 52
    Hecht MH, Richardson JS, Richardson DC, Ogden RC ( 1990). De novo design, expression, and characterization of Felix: a four-helix bundle protein of native-like sequence. Science 249: 884–891.
  • 53
    Richardson JS, Richardson DC ( 2002). Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci USA 99: 2754–2759.
  • 54
    Wang W, Hecht MH ( 2002). Rationally designed mutations convert de novo amyloid-like fibrils into monomeric β-sheet proteins. Proc Natl Acad Sci USA 99: 2760–2765.
  • 55
    Otzen DE, Kristensen O, Oliveberg M ( 2000). Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly. Proc Natl Acad Sci USA 97: 9907–1992.
  • 56
    Inouye H, Kirschner DA ( 2006). X-ray fiber and powder diffraction of PrP prion peptides. Adv Prot Chem 73: 181–215.
  • 57
    Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, Thompson MJ, Balbirnie M, Wiltzius JJ, Mcfarlane HT ( 2007). Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447: 453–457.
  • 58
    Goux WJ, Kopplin L, Nguyen AD, Leak K, Rutkofsky M, Shanmuganandam VD, Sharma D, Inouye H, Kirschner DA ( 2004). The formation of straight and twisted filaments from short tau peptides. J Biol Chem 279: 26868–26875.
  • 59
    Balbach JJ, Ishii Y, Antzutkin ON, Leapman RD, Rizzo NW, Dyda F, Reed J, Tycko R ( 2000). Amyloid fibril formation by A beta 16–22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 39: 13748–13759.
  • 60
    Reches M, Gazit E ( 2004). Amyloidogenic hexapeptide fragment of medin: homology to functional islet amyloid polypeptide fragments. Amyloid 11: 81–89.
  • 61
    Reches M, Porat Y, Gazit E ( 2002). Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin. J Biol Chem 277: 35475–35480.
  • 62
    Haspel N, Zanuy D, Ma B, Wolfson H, Nussinov R ( 2005). A comparative study of amyloid fibril formation by residues 15–19 of the human calcitonin hormone: a single beta-sheet model with a small hydrophobic core. J Mol Biol 1213–1227.
  • 63
    Tenidis K, Waldner M, Bernhagen J, Fischle W, Bergmann M, Weber M, Merkle ML, Voelter W, Brunner H, Kapurniotu A ( 2000). Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J Mol Biol 295: 1055–1071.
  • 64
    Madine J, Doig AJ, Middleton DA ( 2008). Design of an N-methylated peptide inhibitor of α-synuclein aggregation guided by solid-state NMR. J Am Chem Soc 130: 7873–7881.
  • 65
    Laskowski RA, Hutchinson EG, Michie AD, Wallace AC, Jones ML, Thornton JM ( 1997). PDBsum: A Web-based database of summaries and analyses of all PDB structures. Trends Biochem Sci 22: 488–490.
  • 66
    Laskowski RA, Chistyakov VV, Thornton JM ( 2005). PDBsum more: new summaries and analyses of the known 3D structures of proteins and nucleic acids. Nucl Acids Res 33: D266–D268.
  • 67
    Wang GL, Dunbrack RL ( 2003). PISCES: a protein sequence culling server. Bioinformatics 19: 1589–1591.
  • 68
    El-Agnaf OMA, Irvine GB ( 2002). Aggregation and neurotoxicity of α-synuclein and related peptides. Biochem Soc Trans 30: 559–565.
  • 69
    Giasson BI, Murray IVJ, Trojanowski JQ, Lee VMY ( 2001). A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly. J Biol Chem 276: 2380–2386.
  • 70
    Madine J, Doig AJ, Middleton DA ( 2004). The aggregation and membrane-binding properties of an α-synuclein peptide fragment. Biochem Soc Trans 32: 1127–1129.
  • 71
    El-Agnaf OM, Jakes R, Curran MD, Middleton D, Ingenito R, Bianchi E, Pessi A, Neill D, Wallace A ( 1998). Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett 440: 71–76.
  • 72
    Hamada D, Tanaka T, Tartaglia GG, Pawar A, Vendruscolo M, Kawamura M, Tamura A, Tanaka N, Dobson CM ( 2009). Competition between Folding, Native-State Dimerisation and Amyloid Aggregation in β-Lactoglobulin. J Mol Biol 386: 878–890.
  • 73
    Iwata K, Fujiwara T, Matsuki Y, Akutsu H, Takahashi S, Naiki H, Goto Y ( 2006). 3D structure of amyloid protofilaments of beta2-microglobulin fragment probed by solid-state NMR. Proc Natl Acad Sci USA 103: 18119–18124.
  • 74
    Jones S, Manning J, Kad NM, Radford SE ( 2003). Amyloid-forming peptides from β2-microglobulin-Insights into the mechanism of fibril formation in vitro. J Mol Biol 325: 249–257.
  • 75
    Ivanova MI, Thompson MJ, Eisenberg D ( 2006). A systematic screen of β-microglobulin and insulin for amyloid-like segments. Proc Natl Acad Sci USA 103: 4079–4082.
  • 76
    Bemporad F, Taddei N, Stefani M, Chiti F ( 2006). Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase. Protein Sci 15: 862–870.
    Direct Link:
  • 77
    Kallijarvi J, Haltia M, Baumann MH ( 2001). Amphoterin includes a sequence motif which is homologous to the Alzheimer's β-amyloid peptide (Aβ), forms amyloid fibrils in vitro, and binds avidly to Aβ. Biochemistry 40: 10032–10037.
  • 78
    Gross M, Wilkins DK, Pitkeathly MC, Chung EW, Higham C, Clark A, Dobson CM ( 1999). Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB. Protein Sci 8: 1350–1357.
    Direct Link:
  • 79
    Wilkins DK, Dobson CM, Gross M ( 2000). Biophysical studies of the development of amyloid fibrils from a peptide fragment of cold shock protein B. Eur J Biochem 267: 2609–2616.
    Direct Link:
  • 80
    Maury CP, Nurmiaho-Lassila EL ( 1992). Creation of amyloid fibrils from mutant Asn187 gelsolin peptides. Biochem Biophys Res Commun 183: 227–231.
  • 81
    Gazit E ( 2005). Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool. FEBS J 272: 5971–5978.
    Direct Link:
  • 82
    Pertinhez TA, Bouchard M, Smith RA, Dobson CM, Smith LJ ( 2002). Stimulation and inhibition of fibril formation by a peptide in the presence of different concentrations of SD. FEBS Lett 529: 193–197.
  • 83
    Yuan C, Berscheit HL, Huang AJ ( 2007). Identification of an amyloidogenic region on keratoepithelin via synthetic peptides. FEBS Lett 581: 241–247.
  • 84
    Nilsson MR, Dobson CM ( 2003). In vitro characterization of lactoferrin aggregation and amyloid formation. Biochemistry 42: 375–382.
  • 85
    Kasai S, Urushibata S, Hozumi K, Yokoyama F, Ichikawa N, Kadoya Y, Nishi N, Watanabe N, Yamada Y, Nomizu M ( 2007). Identification of multiple amyloidogenic sequences in laminin-1. Biochemistry 46: 3966–3974.
  • 86
    Frare E, Mossuto MF, Polverino De Laureto P, Dumoulin M, Dobson CM, Fontana A ( 2006). Identification of the core structure of lysozyme amyloid fibrils by proteolysis. J Mol Biol 361: 551–561.
  • 87
    Larsson A, Söderberg L, Westermark GT, Sletten K, Engström U, Tjernberg LO, Näslund J, Westermark P ( 2007). Unwinding fibril formation of medin, the peptide of the most common form of human amyloid. 361: 822–828.
  • 88
    Häggqvist B, Näslund J, Sletten K, Westermark GT, Mucchiano G, Tjernberg LO, Nordstedt C, Engström U, Westermark P ( 1999). Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. Proc Natl Acad Sci USA 96: 8669–8674.
  • 89
    Picotti P, De Franceschi G, Frare E, Spolaore B, Zambonin M, Chiti F, De Laureto PP, Fontana A ( 2007). Amyloid fibril formation and disaggregation of fragment 1–29 of apomyoglobin: insights into the effect of pH on protein fibrillogenesis. J Mol Biol 367: 1237–1245.
  • 90
    Satheeshkumar KS, Jayakumar R ( 2003). Conformational polymorphism of the amyloidogenic peptide homologous to residues 113–127 of the prion protein. Biophys J 85: 473–483.
  • 91
    Torrent J, Alvarez-Martinez MT, Liautard JP, Balny C, Lange R ( 2005). The role of the 132–160 region in prion protein conformational transitions. Protein Sci 14: 956–967.
    Direct Link:
  • 92
    Jones EM, Surewicz K, Surewicz WK ( 2006). Role of N-terminal familial mutations in prion protein fibrillization and prion amyloid propagation in vitro. J Biol Chem 281: 8190–8196.
  • 93
    Thompson A, White AR, Mclean C, Masters CL, Cappai R, Barrow CJ ( 2000). Amyloidogenicity and neurotoxicity of peptides corresponding to the helical regions of PrP(C). J Neurosci Res 62: 293–301.
    Direct Link:
  • 94
    Westermark P, Eriksson L, Engstrom U, Enestrom S, Sletten K ( 1997). Prolactin-derived amyloid in the aging pituitary gland. Am J Pathol 150: 67–73.
  • 95
    Giraldo R ( 2007). Defined DNA sequences promote the assembly of a bacterial protein into distinct amyloid nanostructures. Proc Natl Acad Sci USA 104: 17388–17393.
  • 96
    Jaroniec CP, Macphee CE, Astrof NS, Dobson CM, Griffin RG ( 2002). Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril. Proc Natl Acad Sci USA 99: 16748–16753.
  • 97
    Jaroniec CP, Macphee CE, Bajaj VS, Mcmahon MT, Dobson CM, Griffin RG ( 2004). High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. Proc Natl Acad Sci USA 101: 711–716.
  • 98
    Mazor Y, Gilead S, Benhar I, Gazit E ( 2002). Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide. J Mol Biol 322: 1013–1024.
  • 99
    Wiltzius JJ, Sievers SA, Sawaya MR, Cascio D, Popov D, Riekel C, Eisenberg D ( 2008). Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin). Protein Sci 17: 1467–1474.
    Direct Link:
  • 100
    Tashiro K, Sephel GC, Weeks B, Sasaki M, Martin GR, Kleinman HK, Yamada Y ( 1989). A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. J Biol Chem 264: 16174–16182.
  • 101
    Yamada M, Kadoya Y, Kasai S, Kato K, Mochizuki M, Nishi N, Watanabe N, Kleinman HK, Yamada Y, Nomizu M ( 2002). Ile-Lys-Val-Ala-Val (IKVAV)-containing laminin alpha1 chain peptides form amyloid-like fibrils. FEBS Lett 530: 48–52.
  • 102
    Tagliavini F, Prelli F, Verga L, Giaccone G, Sarma R, Gorevic P, Ghetti B, Passerini F, Ghibaudi E, Forloni G ( 1993). Synthetic peptides homologous to prion protein residues 106–147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci USA 90: 9678–9682.
  • 103
    Linding R, Schymkowitz J, Rousseau F, Diella F, Serrano L ( 2004). A comparative study of the relationship between protein structure and β-aggregation in globular and intrinsically disordered proteins. J Mol Biol 342: 345–353.
  • 104
    Crescenzi O, Tomaselli S, Guerrini R, Salvadori S, D'ursi AM, Temussi PA, Picone D ( 2002). Solution structure of the Alzheimer amyloid beta-peptide (1–42) in an apolar microenvironment. Similarity with a virus fusion domain. Eur J Biochem 269: 5642–5648.
    Direct Link:
  • 105
    Kim W, Hecht MH ( 2006). Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide. Proc Natl Acad Sci USA 103: 15824–15829.
  • 106
    Monsellier E, Chiti F ( 2007). Prevention of amyloid-like aggregation as a driving force of protein evolution. EMBO Rep 8: 737–742.
  • 107
    Sutherland TD, Young JH, Weisman S, Hayashi CY, Merritt DJ ( 2010). Insect silk: one name, many materials. Ann Rev Entomol 55: 171–188.
  • 108
    Weisman S, Okada S, Mudie ST, Huson MG, Trueman HE, Sriskantha A, Haritos VS, Sutherland TD ( 2009). Fifty years later: The sequence, structure and function of lacewing cross-beta silk. J Struct Biol 168: 467–475.
  • 109
    Guex N, Peitsch MC ( 1997). SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714– 2723.
    Direct Link:
  • 110
    Hubbard SJ, Thornton JM ( 1993). NACCESS' computer program, Department of Biochemistry and Molecular Biology, University College London. Available at http://www.bioinf.manchester.ac.uk/naccess/.
  • 111
    Willard L, Ranjan A, Zhang H, Monzavi H, Boyko RF, Sykes BD, Wishart DS ( 2003). VADAR: a web server for quantitative evaluation of protein structure quality. Nucl Acids Res 31: 3316–3319.
  • 112
    Fauchere JL, Pliska V ( 1983). Hydrophobic parameters π of amino-acid side chains from the partitioning of N-acetyl-amino-acid amides. Eur J Med Chem-Chim Ther 18: 369–375.
  • 113
    Team RDC ( 2008). R: A language and environment for statistical computing, Vienna, Austria: R Foundation for Statistical Computing, ISBN 3-900051-07–0. Available at: http://www.R-project.org.
  • 114
    Frishman D, Argos P ( 1995). Knowledge-based protein secondary structure assignment. Proteins 23: 566–579.
    Direct Link:
View Full Article with Supporting Information (HTML) Get PDF (392K)